Yu M, Wang T, Xu C, Bi Y, et al. Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025). Diabetes Obes Metab 2025 Oct 14. doi: 10.1111/dom.70197.
PMID: 41084961